Email This Press Releases

Q BioMed Inc. Provides Important Update on Mannin Research Tie2 Technology Platform Development

Q BioMed Inc., a commercial stage biotechnology acceleration development company, provides the following update on its exclusively licensed platform technology asset from Mannin Research Inc.

View full press release

  • We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy